Evidence map›Paper›PMID 24659344›Full record

ReviewCurrent HIV/AIDS reports2014

A lifecycle approach to HIV prevention in African women and children.

Alison C Roxby, Jennifer A Unger, Jennifer A Slyker, John Kinuthia, Andrew Lewis, Grace John-Stewart, Judd L Walson

Open access · greenAbstract readReview
In one paragraph

Review in Current HIV/AIDS reports, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. HIV Replication in LEGO Mosaic.AIDS research and human retroviruses · 2015
    Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Alison C Roxby
Jennifer A Unger
Jennifer A Slyker
John Kinuthia
Andrew Lewis
Grace John-Stewart
Judd L Walson
University of Washington · USKenyatta National Hospital · KE

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI EDWIN ROBERTO ORELLANA · 1988 to 2026
$104.9M
Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infectionsR01HD023412 · NICHD · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart, DALTON CHEKOKO WAMALWA · 1987 to 2026
$12.2M
Prevalence and Correlates of NTS Bacteremia, Diarrhea and Carriage in KenyaU19AI090882 · NIAID · UNIVERSITY OF WASHINGTON · PI KEMNER, JOHN M · 2010 to 2014
$5.6M
Linked-Strengthening Maternal, Newborn & Child Health Research Training in KenyaR24TW008907 · FIC · UNIVERSITY OF NAIROBI · PI KIBWAGE, ISAAC ONGUBO · 2010 to 2014
$2.2M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
HIV Testing and Educating Male Partners to Improve Maternal and Infant OutcomesR01HD075108 · NICHD · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY · 2012 to 2013
$684k
Immune activation during pregnancy and contraception in HIV-infected Kenyan womenK23HD071788 · NICHD · UNIVERSITY OF WASHINGTON · PI ROXBY, ALISON CHRISTINA · 2012 to 2016
$648k
Vertical CMV transmission in the setting of maternal HIV-1 infection in KenyaK01AI087369 · NIAID · UNIVERSITY OF WASHINGTON · PI SLYKER, JENNIFER ANN · 2010 to 2014
$616k
FIC NIH HHS 1R24TW008907FIC NIH HHS R24 TW008907NIAID NIH HHS K01 AI087369NIAID NIH HHS P01 AI082976-01NIAID NIH HHS P30 AI027757NIAID NIH HHS U19 AI 090882NIAID NIH HHS U19 AI090882NICHD NIH HHS K12 HD09026NICHD NIH HHS K23 HD071788NICHD NIH HHS K23 HD071788-01A1NICHD NIH HHS K24 HD054314NICHD NIH HHS R01 HD023412NICHD NIH HHS R01 HD023412-21NICHD NIH HHS R01 HD075108NICHD NIH HHS R01-HD075108
6 · The paper itself

Abstract

Effective biomedical and structural HIV prevention approaches are being implemented throughout sub-Saharan Africa. A "lifecycle approach" to HIV prevention recognizes the interconnectedness of the health of women, children and adolescents, and prioritizes interventions that have benefits across these populations. We review new biomedical prevention strategies for women, adolescents and children, structural prevention approaches, and new modalities for eliminating infant HIV infection, and discuss the implications of a lifecycle approach for the success of these methods. Some examples of the lifecycle approach include evaluating education and HIV prevention strategies among adolescent girls not only for their role in reducing risk of HIV infection and early pregnancy, but also to promote healthy adolescents who will have healthier future children. Similarly, early childhood interventions such as exclusive breastfeeding not only prevent HIV, but also contribute to better child and adolescent health outcomes. The most ambitious biomedical infant HIV prevention effort, Option B+, also represents a lifecycle approach by leveraging the prevention benefits of optimal HIV treatment for mothers; maternal survival benefits from Option B+ may have ultimately more health impact on children than the prevention of infant HIV in isolation. The potential for synergistic and additive benefits of lifecycle interventions should be considered when scaling up HIV prevention efforts in sub-Saharan Africa.

Indexed as

AdolescentAdolescent Health ServicesAfrica South of the SaharaAnti-HIV AgentsChildChild Health ServicesChild, PreschoolFamilyFemaleHIV InfectionsHumansIncidenceInfantInfectious Disease Transmission, VerticalMaleMaternal Health ServicesAnti-HIV Agents

Identifiers

PMID24659344
PMCPMC4077944
OpenAlexW2039957051

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.